Results 101 to 110 of about 1,438,673 (245)

Covert hepatic encephalopathy: a neglected topic—a narrative review

open access: yesEgyptian Liver Journal
Covert hepatic encephalopathy (CHE) is a form of cerebral dysfunction that affects 30–40% of patients with liver cirrhosis as a grave sequel of disease progression. Although being a silent condition, yet; CHE has been reported as seriously predictive for
Mohamed Elbadry   +10 more
doaj   +1 more source

Treatment of hepatic encephalopathy

open access: yes, 2007
Current recommendations for the treatment of hepatic encephalopathy are based, to a large extent, on open or uncontrolled trials, undertaken in very small numbers of patients.
M. Y. Morgan   +8 more
core  

Challenges in Gene‐Directed Therapies for Rare Neurodevelopmental Disorders Using HNRNPU as an Exemplar

open access: yesClinical Genetics, EarlyView.
Beyond diagnosing rare neurodevelopmental disorders like HNRNPU‐RNDD, developing gene‐directed therapies requires overcoming complex hurdles, including spatial, developmental, and cell‐type constraints. Addressing these requires understanding the molecular effects of dosage and chromatin dynamics to deliver precise, effective treatments.
Daniel Aiyedun   +3 more
wiley   +1 more source

Rapid identification system of frontal dysfunction in subclinical hepatic encephalopathy

open access: yesAnnals of Hepatology, 2016
Introduction and aim. Liver disease is associated with cognitive dysfunction also at early stages, and minimal hepatic encephalopathy, affecting 20-70% of patients, is frequently under-recognized.
Rita Moretti   +6 more
doaj   +1 more source

Nutrition and Hepatic Encephalopathy

open access: yes, 2012
This Chapter evaluates the correlation between malnutrition and hepatic encephalopathy in liver ...
MERLI, Manuela   +5 more
core   +1 more source

Genetic testing in paediatric neurological disorders

open access: yesDevelopmental Medicine &Child Neurology, EarlyView.
In this study 390 paediatric patients with neurological disorders underwent genetic testing via exome sequencing, commercial panel, in‐house epilepsy, and movement disorder gene panels. Exome sequencing provides the highest diagnostic yield, and severe developmental delay and hypotonia predicted pathogenic variants in the exome sequencing cohort ...
Wafa Bani Uraba   +15 more
wiley   +1 more source

The Psychometric Hepatic Encephalopathy Score for Diagnosis of Minimal Hepatic Encephalopathy in Liver Cirrhosis Patient

open access: yesThe Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy
Introduction: The psychometric hepatic encephalopathy score (PHES) is a tool that can be considered as a gold standard for detecting minimal hepatic encephalopathy (MHE) in liver cirrhosis patients.
Cokorde Istri Yuliandari Krisnawardani Kumbara   +2 more
doaj   +1 more source

Covering the Cover

open access: yesThe Turkish Journal of Gastroenterology, 2017
Critical flicker frequency test for diagnosing minimal hepatic encephalopathy in patients with ...
Müjdat Zeybel
doaj   +1 more source

Clinical characteristics of cirrhotic patients with and without minimal hepatic encephalopathy (MHE).

open access: yes, 2015
Interleukin-6 (IL-6); Tumor necrosis factor-α (TNF-α); Hospital Anxiety and Depression Scale (HADS).Clinical characteristics of cirrhotic patients with and without minimal hepatic encephalopathy (MHE).
Ching-Liang Lu (404817)   +7 more
core   +1 more source

Dysglycemia during neonatal encephalopathy and early school‐age neurodevelopmental outcomes

open access: yesDevelopmental Medicine &Child Neurology, EarlyView.
In the era of therapeutic hypothermia, hyperglycemia and increased glucose variability during the first few days of life are associated with worse neurodevelopmental outcomes at early school‐age in survivors of neonatal encephalopathy. These associations are fully explained by neonatal brain injury and/or paternal education.
Daphne Kamino   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy